Miglietta A, Gadoni E, Buffa M, Olivero A, Gabriel L
Dipartimento di Medicina e Oncologia Sperimentale, University of Torino, Italy.
Eur J Drug Metab Pharmacokinet. 1995 Oct-Dec;20(4):249-54. doi: 10.1007/BF03190240.
In this study we examined the interactions of liver microsomes with the antibiotic calvatic acid and with structural analogues, some of which had shown antimicrotubular properties. These drugs decreased cytochrome P-450 content differently according to the substitutions on the azoxy function and the ethoxycarbonyl derivatives were found to be the most effective ones. The decrease in cytochrome P-450 could be prevented by addition of cysteine or GSH, suggesting an involvement of sulphydryl groups. Furthermore, chromatographic analyses showed that ethoxycarbonyl derivatives were completely metabolized, and this would explain the different behaviour of these compounds towards microtubular protein when they were incubated with purified bovine brain protein or with liver or hepatoma extracts.
在本研究中,我们检测了肝微粒体与抗生素卡尔伐酸及其结构类似物的相互作用,其中一些类似物已显示出抗微管特性。这些药物根据偶氮氧基官能团上的取代基不同程度地降低了细胞色素P-450的含量,并且发现乙氧羰基衍生物是最有效的。加入半胱氨酸或谷胱甘肽可防止细胞色素P-450的减少,这表明巯基参与其中。此外,色谱分析表明乙氧羰基衍生物被完全代谢,这可以解释这些化合物在与纯化的牛脑蛋白或肝脏或肝癌提取物孵育时对微管蛋白的不同作用。